Patents by Inventor Frederik DENORME

Frederik DENORME has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
    Publication number: 20210128701
    Abstract: Provided herein are methods for recanalization of occluded blood vessels in a subject having an infarction. The method includes a step of administering to the subject a therapeutically effective amount of isolated ADAMTS13 protein at particular dosages and ranges of times after detection of the infarction. As described herein, ADAMTS13 advantageously recanalizes occluded blood vessels and reduces infarction size, even when administered a prolonged period after stable occlusion. Accordingly, such methods and compositions are useful for the treatment of infractions caused by blood vessel occlusion.
    Type: Application
    Filed: October 3, 2019
    Publication date: May 6, 2021
    Applicants: Baxalta Incorporated, Baxalta GmbH, Katholieke Universiteit Leuven
    Inventors: Barbara PLAIMAUER, Hanspeter Rottensteiner, Friedrich Scheiflinger, Simon De Meyer, Frederik Denorme
  • COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
    Publication number: 20180110842
    Abstract: Provided herein are methods for recanalization of occluded blood vessels in a subject having an infarction. The method includes a step of administering to the subject a therapeutically effective amount of isolated ADAMTS13 protein at particular dosages and ranges of times after detection of the infarction. As described herein, ADAMTS13 advantageously recanalizes occluded blood vessels and reduces infarction size, even when administered a prolonged period after stable occlusion. Accordingly, such methods and compositions are useful for the treatment of infractions caused by blood vessel occlusion.
    Type: Application
    Filed: May 26, 2016
    Publication date: April 26, 2018
    Applicants: Baxalta Incorporated, Baxalta GmbH, Katholieke Universiteit Leuven
    Inventors: Barbara PLAIMAUER, Hanspeter ROTTENSTEINER, Friedrich SCHEIFLINGER, Simon DE MEYER, Frederik DENORME